DRW Securities LLC Boosts Stock Holdings in Becton, Dickinson and Company (NYSE:BDX)

DRW Securities LLC lifted its stake in Becton, Dickinson and Company (NYSE:BDX) by 8.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,312 shares of the medical instruments supplier’s stock after buying an additional 105 shares during the period. DRW Securities LLC’s holdings in Becton, Dickinson and Company were worth $307,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Livelsberger Financial Advisory purchased a new stake in shares of Becton, Dickinson and Company during the fourth quarter valued at approximately $27,000. OLD Point Trust & Financial Services N A purchased a new stake in shares of Becton, Dickinson and Company during the fourth quarter worth about $29,000. Scarborough Advisors LLC bought a new stake in shares of Becton, Dickinson and Company in the fourth quarter worth about $32,000. Rise Advisors LLC purchased a new position in Becton, Dickinson and Company during the 1st quarter valued at about $38,000. Finally, ICA Group Wealth Management LLC bought a new position in Becton, Dickinson and Company during the 4th quarter valued at approximately $42,000. Institutional investors own 86.97% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on BDX shares. Raymond James dropped their price target on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating for the company in a research note on Friday, August 2nd. Stifel Nicolaus raised their price objective on shares of Becton, Dickinson and Company from $270.00 to $280.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Evercore ISI reduced their target price on Becton, Dickinson and Company from $290.00 to $285.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. StockNews.com upgraded Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a report on Thursday, August 8th. Finally, The Goldman Sachs Group initiated coverage on shares of Becton, Dickinson and Company in a report on Thursday, May 30th. They set a “buy” rating and a $274.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, Becton, Dickinson and Company has an average rating of “Moderate Buy” and an average price target of $279.50.

Becton, Dickinson and Company Trading Up 0.5 %

NYSE BDX opened at $234.70 on Tuesday. Becton, Dickinson and Company has a 12 month low of $218.75 and a 12 month high of $269.52. The company has a current ratio of 1.85, a quick ratio of 1.36 and a debt-to-equity ratio of 0.70. The stock’s fifty day moving average price is $235.68 and its 200-day moving average price is $235.52. The stock has a market cap of $67.83 billion, a P/E ratio of 51.70, a P/E/G ratio of 1.91 and a beta of 0.42.

Becton, Dickinson and Company (NYSE:BDX) last released its quarterly earnings data on Thursday, August 1st. The medical instruments supplier reported $3.50 earnings per share for the quarter, beating analysts’ consensus estimates of $3.31 by $0.19. Becton, Dickinson and Company had a net margin of 7.13% and a return on equity of 14.49%. The business had revenue of $4.99 billion during the quarter, compared to analyst estimates of $5.08 billion. During the same period last year, the business earned $2.96 EPS. Becton, Dickinson and Company’s revenue was up 2.3% compared to the same quarter last year. As a group, equities analysts forecast that Becton, Dickinson and Company will post 13.1 EPS for the current fiscal year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 9th will be issued a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date is Monday, September 9th. Becton, Dickinson and Company’s payout ratio is 83.70%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.